Document ref: CW-IJ-001
21 CFR 211.192 · 211.22(a)
The cost of one reconstructed authorization record exceeds the cost of a year of membership.
For Finance, Quality Leadership, or the Compliance Program Owner reviewing the ComplianceWorxs purchase. Read it once. Hand it across the desk.
Section 1 — The Decision Already Made
Your team has authorized hundreds of compliance decisions. Few of them have an authorization record.
Batch releases. CAPA closures. Deviation dispositions. OOS investigations. Change control categorizations. Every one of them has a signature.
That is not a documentation failure. The signatures exist. The dispositions are in the QMS. The CAPAs are closed.
What does not exist is the second record. The one that captures who reviewed which evidence against which standard and concluded the decision was acceptable at the moment it was authorized.
That second record is what an FDA investigator asks for.
Section 2 — The Cost When That Record Cannot Be Produced
The exposure on a single Form 483 observation citing missing authorization logic.
Per observation under 21 CFR 211.192
If the 483 escalates to a Warning Letter
The cost is not theoretical. It is the cost the company pays the day the investigator writes it down.
Section 3 — What ComplianceWorxs Costs
The membership pricing, for direct comparison.
Section 4 — The Comparison That Matters
One year of membership against one observation.
The annual Individual Membership cost is less than two hours of senior QA leadership time during an active inspection.
The annual Team Membership cost is less than the remediation cost of a single 483 observation at the low end of the range.
The annual Enterprise Membership cost is less than the retainer for one Big Four remediation engagement that follows a Warning Letter.
The question is not whether the membership is worth it. The question is whether the company has ever been asked to reconstruct an authorization record under inspection pressure — and whether it would prefer to never be asked that question again.
Section 5 — What to Confirm Before Approving
Three items. If any cannot be confirmed, the cost of not having ComplianceWorxs is higher than the cost of having it.
- The quality team can name the last 24 months of inspection-critical decisions by signatory.
- For each one, the authorization record exists as a contemporaneous artifact — not as a reconstruction.
- If the FDA pulled 24 batch records tomorrow, the authorization logic behind each release decision could be produced in the time the investigator expects.
ComplianceWorxs is the record that answers.